Authors: WIJMENGA C VANDENHEUVEL L STRENGMAN E LUYTEN J VANDERBURGT I DEGROOT R SMEETS D VANDONGEN J PEARSON P SANDKUIJL L WEEMAES C

Citation: C. Wijmenga et al., LOCALIZATION OF ICF SYNDROME BY HOMOZYGOSITY MAPPING, Molecular immunology, 35(11-12), 1998, pp. 719-719

Authors: COWLEY DM BOWLING FG MCGILL JJ VANDONGEN J MORRIS D

Citation: Dm. Cowley et al., ADULT-ONSET ARGINASE DEFICIENCY, Journal of inherited metabolic disease, 21(6), 1998, pp. 677-678

Authors: KEMPERMAN H BORGER J HART A PETERSE H BARTELINK H VANDONGEN J

Citation: H. Kemperman et al., PROGNOSTIC FACTORS FOR SURVIVAL AFTER BREAST-CONSERVING THERAPY FOR STAGE-I AND STAGE-II BREAST-CANCER - THE ROLE OF LOCAL RECURRENCE, European journal of cancer, 31A(5), 1995, pp. 690-698

Authors: CASTROP J VANWICHEN D KOOMANSBITTER M VANDEWETERING M DEWEGER R VANDONGEN J CLEVERS H

Citation: J. Castrop et al., THE HUMAN TCF-1 GENE ENCODES A NUCLEAR DNA-BINDING PROTEIN UNIQUELY EXPRESSED IN NORMAL AND NEOPLASTIC T-LINEAGE LYMPHOCYTES, Blood, 86(8), 1995, pp. 3050-3059

Authors: BORGER J KEMPERMAN H HART A PETERSE H VANDONGEN J BARTELINK H

Citation: J. Borger et al., RISK-FACTORS IN BREAST-CONSERVATION THERAPY, Journal of clinical oncology, 12(4), 1994, pp. 653-660

Authors: BORGER JH KEMPERMAN H SMITT HS HART A VANDONGEN J LEBESQUE J BARTELINK H

Citation: Jh. Borger et al., DOSE AND VOLUME EFFECTS ON FIBROSIS AFTER BREAST-CONSERVATION THERAPY, International journal of radiation oncology, biology, physics, 30(5), 1994, pp. 1073-1081